Michael Scott Maguire
Founder at Healthcare Capital Partners Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Colin William Hill | M | 79 |
Lipoxen Technologies Ltd.
 Lipoxen Technologies Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1997, Lipoxen Technologies Ltd. is a British company that specializes in product development in the pharmaceutical industry. Part of Xenetic Biosciences, Inc., the company is based in London, UK.
Xenetic Biosciences (UK) Ltd.
 Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 17 years |
| Stefano Ciampolini | M | 55 |
DaVita (UK) Ltd.
 DaVita (UK) Ltd. Medical/Nursing ServicesHealth Services DaVita (UK) Ltd. provides dialysis services. It manages all aspects of dialysis care at its centers including clinical, quality control, data collection, diagnostics and maintenance services. The company was founded by Stefano Ciampolini and Michael Scott Maguire in 2007 and is headquartered in London, the United Kingdom.
DaVita (UK) Trading Ltd.
 DaVita (UK) Trading Ltd. Medical/Nursing ServicesHealth Services Part of DaVita, Inc., DaVita (UK) Trading Ltd. is a British company that provides faculty management services for dialysis treatment. The company is based in London, UK and was founded in 2011.
Boss Enterprises Group LLC
 Boss Enterprises Group LLC Investment ManagersFinance Boss Enterprises Group LLC (The Boss Group) is a private equity firm founded in 2004 by George Boss. The firm is headquartered in Houston, Texas. | 14 years |
| James Parslow | M | 59 |
Lipoxen Technologies Ltd.
Lipoxen Technologies Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1997, Lipoxen Technologies Ltd. is a British company that specializes in product development in the pharmaceutical industry. Part of Xenetic Biosciences, Inc., the company is based in London, UK.
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 7 years |
| George Boss | M | - |
Boss Enterprises Group LLC
Boss Enterprises Group LLC Investment ManagersFinance Boss Enterprises Group LLC (The Boss Group) is a private equity firm founded in 2004 by George Boss. The firm is headquartered in Houston, Texas. | 20 years |
| Firdaus Jal Dastoor | M | 72 |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 17 years |
| Stephen Spinelli | M | 69 |
Babson College
| 31 years |
| Roger Kornberg | M | 77 | 8 years | |
| James Callaway | M | 68 | 7 years | |
| Adam Logal | M | 46 | 7 years | |
| David Hogg | M | 54 |
Cannaray Ltd.
 Cannaray Ltd. Chemicals: Major DiversifiedProcess Industries Cannaray Ltd. engages in a cannabis company. It manufactures cannabis related products with THC-free and GMO-free. The company was founded on December 7, 2018 and is headquartered in Cobham, the United Kigndom. | - |
| Nigel Knowles | M | 68 |
Cannaray Ltd.
Cannaray Ltd. Chemicals: Major DiversifiedProcess Industries Cannaray Ltd. engages in a cannabis company. It manufactures cannabis related products with THC-free and GMO-free. The company was founded on December 7, 2018 and is headquartered in Cobham, the United Kigndom.
Cannaray Brands Ltd.
 Cannaray Brands Ltd. Internet RetailRetail Trade Part of Cannaray Ltd., Cannaray Brands Ltd. is a British company that provides CBD products with free delivery and no minimum spend. The private company is based in London, UK. Customers can return their products within 14 days. The company offers an affiliate program where individuals can earn commission by recommending their premium CBD products. The company was founded in 2019. The CEO is Michael Scott Maguire. | - |
| Anne Orton Boss | F | - |
Boss Enterprises Group LLC
Boss Enterprises Group LLC Investment ManagersFinance Boss Enterprises Group LLC (The Boss Group) is a private equity firm founded in 2004 by George Boss. The firm is headquartered in Houston, Texas. | 17 years |
| Andrew Garden | M | - |
Cannaray Brands Ltd.
Cannaray Brands Ltd. Internet RetailRetail Trade Part of Cannaray Ltd., Cannaray Brands Ltd. is a British company that provides CBD products with free delivery and no minimum spend. The private company is based in London, UK. Customers can return their products within 14 days. The company offers an affiliate program where individuals can earn commission by recommending their premium CBD products. The company was founded in 2019. The CEO is Michael Scott Maguire. | 2 years |
| Chris Sullivan | M | - |
Cannaray Brands Ltd.
Cannaray Brands Ltd. Internet RetailRetail Trade Part of Cannaray Ltd., Cannaray Brands Ltd. is a British company that provides CBD products with free delivery and no minimum spend. The private company is based in London, UK. Customers can return their products within 14 days. The company offers an affiliate program where individuals can earn commission by recommending their premium CBD products. The company was founded in 2019. The CEO is Michael Scott Maguire. | - |
| Philip Michael Culbertson | M | 46 |
Love Cbd Health Ltd.
 Love Cbd Health Ltd. Pharmaceuticals: OtherHealth Technology Part of Cannaray Ltd., Love CBD Health Ltd. is a family business that was founded in 2014. The company is based in Burwell, UK and offers a range of premium CBD and Hemp products to promote health and wellness. Love CBD is the most-reviewed CBD brand with a focus on bringing the best quality CBD oil and hemp products to the market. | 4 years |
| Daniel Philip Culbertson | M | 48 |
Love Cbd Health Ltd.
Love Cbd Health Ltd. Pharmaceuticals: OtherHealth Technology Part of Cannaray Ltd., Love CBD Health Ltd. is a family business that was founded in 2014. The company is based in Burwell, UK and offers a range of premium CBD and Hemp products to promote health and wellness. Love CBD is the most-reviewed CBD brand with a focus on bringing the best quality CBD oil and hemp products to the market. | 4 years |
| Klaus Bak | M | - |
Healthcare Capital Partners Ltd.
| - |
| David John Hogg | M | 54 |
Love Cbd Health Ltd.
Love Cbd Health Ltd. Pharmaceuticals: OtherHealth Technology Part of Cannaray Ltd., Love CBD Health Ltd. is a family business that was founded in 2014. The company is based in Burwell, UK and offers a range of premium CBD and Hemp products to promote health and wellness. Love CBD is the most-reviewed CBD brand with a focus on bringing the best quality CBD oil and hemp products to the market. | - |
| Christopher Sullivan | M | 67 |
Cannaray Ltd.
Cannaray Ltd. Chemicals: Major DiversifiedProcess Industries Cannaray Ltd. engages in a cannabis company. It manufactures cannabis related products with THC-free and GMO-free. The company was founded on December 7, 2018 and is headquartered in Cobham, the United Kigndom. | 5 years |
| Michael Alan Freedman | M | 64 |
Cannaray Ltd.
Cannaray Ltd. Chemicals: Major DiversifiedProcess Industries Cannaray Ltd. engages in a cannabis company. It manufactures cannabis related products with THC-free and GMO-free. The company was founded on December 7, 2018 and is headquartered in Cobham, the United Kigndom. | - |
| Henry Hoppe | M | - |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 12 years |
| Brad Marcus | M | - |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 17 years |
| Sanjay Jain | M | - |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 23 years |
| Prince K. Zachariah | M | - |
Boss Enterprises Group LLC
Boss Enterprises Group LLC Investment ManagersFinance Boss Enterprises Group LLC (The Boss Group) is a private equity firm founded in 2004 by George Boss. The firm is headquartered in Houston, Texas. | - |
| Lawrence L. Michaelis | M | - |
Boss Enterprises Group LLC
Boss Enterprises Group LLC Investment ManagersFinance Boss Enterprises Group LLC (The Boss Group) is a private equity firm founded in 2004 by George Boss. The firm is headquartered in Houston, Texas. | 20 years |
| Nils A. Johansson | M | - |
Boss Enterprises Group LLC
Boss Enterprises Group LLC Investment ManagersFinance Boss Enterprises Group LLC (The Boss Group) is a private equity firm founded in 2004 by George Boss. The firm is headquartered in Houston, Texas. | - |
| Michael Freedman | M | - |
Cannaray Brands Ltd.
Cannaray Brands Ltd. Internet RetailRetail Trade Part of Cannaray Ltd., Cannaray Brands Ltd. is a British company that provides CBD products with free delivery and no minimum spend. The private company is based in London, UK. Customers can return their products within 14 days. The company offers an affiliate program where individuals can earn commission by recommending their premium CBD products. The company was founded in 2019. The CEO is Michael Scott Maguire. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ari L. Nagler | M | - | 1 years | |
| Curtis Lockshin | M | 64 |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 10 years |
| Gregory Gregoriadis | M | - |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 17 years |
| Dmitriy Genkin | M | 56 |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 21 years |
| Jeffrey Eisenberg | M | 58 | 8 years | |
| Timothy E. Smith | M | - |
Babson College
| 11 years |
| Brian Mansel Richards | M | 91 |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 9 years |
| Roman Sergeevich Knyazev | M | 44 |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 7 years |
| Artur Alexandrovich Isaev | M | 54 |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | - |
| Mark Leuchtenberger | M | 67 | 1 years | |
| Adam Robert Jacobs | M | - |
Babson College
| 4 years |
| Yiannos Mouzouris | M | - |
DaVita (UK) Ltd.
DaVita (UK) Ltd. Medical/Nursing ServicesHealth Services DaVita (UK) Ltd. provides dialysis services. It manages all aspects of dialysis care at its centers including clinical, quality control, data collection, diagnostics and maintenance services. The company was founded by Stefano Ciampolini and Michael Scott Maguire in 2007 and is headquartered in London, the United Kingdom. | - |
| Wenche Marie Agerup | F | 60 |
Babson College
| 2 years |
| Howard Field | M | - |
Babson College
| 4 years |
| Michael Cotoia | M | 52 |
Babson College
| 4 years |
| Robert G. Russell | M | - |
Babson College
| 4 years |
| Gary Paul Susel | M | - |
Babson College
| 4 years |
| Mark D. Cordes | M | - |
Babson College
| 4 years |
| Ajay K. Agrawal | M | - |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | - |
| Grant J. Guilbeault | M | - |
Babson College
| 2 years |
| Stig Filip George Engelbert | M | 55 |
Babson College
| 3 years |
| Chris W. Adair | M | - |
Babson College
| 4 years |
| David Moss | M | - |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | - |
| Mohammed Al-Amin Ismail Lutfi Mansour | M | - |
Babson College
| 4 years |
| Gerry Benson | M | - |
Babson College
| 4 years |
| Jeff Fettes | M | - |
Babson College
| 4 years |
| Toni Clayton-Hine | F | - |
Babson College
| 4 years |
| Brian P. Kennedy | M | - |
Babson College
| 1 years |
| Timothy Coté | M | - | - | |
| Gregory Pendy | M | - |
Babson College
| 4 years |
| John Ellsworth | M | - |
Babson College
| 2 years |
| Scott M. Service | M | - |
Babson College
| 4 years |
| George Loucas Tsangarides | M | 38 |
DaVita (UK) Ltd.
DaVita (UK) Ltd. Medical/Nursing ServicesHealth Services DaVita (UK) Ltd. provides dialysis services. It manages all aspects of dialysis care at its centers including clinical, quality control, data collection, diagnostics and maintenance services. The company was founded by Stefano Ciampolini and Michael Scott Maguire in 2007 and is headquartered in London, the United Kingdom. | - |
| Wang Tony Yeung | M | 50 |
Babson College
| 4 years |
| Clive Richard Sharpe | M | 67 |
Cannaray Ltd.
Cannaray Ltd. Chemicals: Major DiversifiedProcess Industries Cannaray Ltd. engages in a cannabis company. It manufactures cannabis related products with THC-free and GMO-free. The company was founded on December 7, 2018 and is headquartered in Cobham, the United Kigndom. | - |
| Edward Stanton McLean | M | 53 |
Cannaray Ltd.
Cannaray Ltd. Chemicals: Major DiversifiedProcess Industries Cannaray Ltd. engages in a cannabis company. It manufactures cannabis related products with THC-free and GMO-free. The company was founded on December 7, 2018 and is headquartered in Cobham, the United Kigndom. | - |
| John Ritacco | M | 53 |
Babson College
| 4 years |
| Danah Al-Husaini | F | - |
Babson College
| 4 years |
| Manoj Narender Madnani | M | 53 |
Babson College
| 4 years |
| Bill Page | M | 61 |
Babson College
| 2 years |
| Steven A. Kempenich | M | - |
Babson College
| 4 years |
| Thomas Lapointe | M | - |
Babson College
| 4 years |
| Walter M. Kelly | M | 54 |
Babson College
| 4 years |
| Feng Bai | M | 54 |
Babson College
| 4 years |
| Hoo Ong Seng | M | 47 |
Babson College
| 4 years |
| Jamie A. Donadio | M | 48 |
Babson College
| 4 years |
| Michael Fung | M | - |
Babson College
| 4 years |
| Mike Feehily | M | - |
Babson College
| 4 years |
| Lloyd Kurtz | M | - |
Babson College
| 2 years |
| Tim B. Murphy | M | 59 |
Babson College
| 4 years |
| Alan Edward Norton | M | 62 |
Babson College
| 2 years |
| Jim Polk | M | - |
Babson College
| 2 years |
| Jeffrey Yale Rubin | M | - |
Babson College
| 4 years |
| Matt Hudson | M | - |
Babson College
| 4 years |
| Scott Edward Madden | M | - |
Babson College
| 4 years |
| Chris Titus | M | - |
Babson College
| 4 years |
| Bill Robert Fearnley | M | - |
Babson College
| 2 years |
| Karl A. Schneider | M | - |
Babson College
| 4 years |
| Robert A. Lee | M | - |
Babson College
| 4 years |
| John W. Donovan | M | - |
Babson College
| 4 years |
| George Aggouras | M | - |
Babson College
| 4 years |
| Scott Peters | M | - |
Babson College
| 4 years |
| Pennock J. Yeatman | M | - |
Babson College
| 4 years |
| James Peter Buckley | M | 62 |
DaVita (UK) Ltd.
DaVita (UK) Ltd. Medical/Nursing ServicesHealth Services DaVita (UK) Ltd. provides dialysis services. It manages all aspects of dialysis care at its centers including clinical, quality control, data collection, diagnostics and maintenance services. The company was founded by Stefano Ciampolini and Michael Scott Maguire in 2007 and is headquartered in London, the United Kingdom. | - |
| Kevin Timothy Grimes | M | - |
Babson College
| 4 years |
| Stephen Kramer | M | 53 |
Babson College
| 4 years |
| Larry P. Begley | M | - |
Babson College
| 2 years |
| Thomas E. Darden | M | - |
Babson College
| 3 years |
| Robert Zlatko Kuftinec | M | - |
Babson College
| 4 years |
| Marcia O'Carroll | F | - |
Babson College
| 2 years |
| Douglas Paul Lewin | M | 54 |
Babson College
| 4 years |
| Tatiana Zhuravskaya | M | - |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | - |
| Brian Dowd | M | - |
Babson College
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 77 | 77.00% |
| United Kingdom | 32 | 32.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael Scott Maguire
- Personal Network
